Updates in Multiple Myeloma: Learners will be able to outline the latest updates for treatment options for patients with newly diagnosed multiple myeloma and highlight novel drug targets in the relapsed/refractory setting. They will also be able to describe best practices for managing complications from treatment such as ocular toxicity, GI toxicity, and febrile neutropenia. 
Speaker: David Hughes, PharmD, BCOP, Boston Medical Center